{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q14116",
      "entity_text" : "IL-18",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10090" ],
      "TissueType" : [ "tissuelist:TS-1001" ],
      "CellType" : [ "cl:CL:0000084" ]
    }
  },
  "verbose_text" : "Additional analysis revealed no emergence of contaminating TCR + CD19-IL-18 CAR T cells during treatment, significant proliferation of TCR KO CD19-IL-18 compared with CD19-GFP CAR T cells (350 versus 10.5 cells / muL blood), a high level of IL-18 in the plasma (77,500 pg/mL on day 10), persistence of CD4 + CD19 - IL-18 CAR T cells, and a primarily T EM phenotype (XREF_FIG).",
  "reading_complete" : "2020-08-08T13:54:20Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T13:52:03Z",
  "trigger" : "level",
  "evidence" : [ "level of IL-18" ],
  "pmc_id" : "6002762",
  "score" : 0
}